Early detection of pancreatic cancer: A possibility in some cases but not a reality in most

Journal of Digestive Diseases

Volumn 13, Issue 8, 2012, Pages 389-392

  Goh, Khean Lee ^a   Yoon, Boon Koon ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Diagnosis; Early detection of cancer; Familial genetic syndrome; Pancreatic neoplasms

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA2 PROTEIN; CA 19-9 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN KINASE LKB1; PROTEIN P16;

ABDOMINAL PAIN; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CYSTIC FIBROSIS; DIABETES MELLITUS; DYSPLASIA; EARLY DIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; LONG TERM CARE; LYMPH NODE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; WEIGHT REDUCTION;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; HUMANS; PANCREATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863868930     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2012.00609.x     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. International Agency for Research on Cancer. Cancer incidence in five continents. Cancer Mondial. Cited: April 10, 2012. Available from URL:
3. Jemal A, Siegel R, Ward E etal. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
4. Vital Statics Japan. 2010. Cancer survival (1993-2002). Ministry of Health, Labour and Welfare. Cited: April 10, 2012. Available from URL:
5. Guo X, Cui Z. Current diagnosis and treatment of pancreatic cancer in China. Pancreas 2005; 31: 13-22.
6. Rulyak SJ, Kimmey MB, Veenstra DL, Brentnall TA. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 2003; 57: 23-9.
7. Screening for Pancreatic Cancer: A Brief Evidence Update for the U.S. Preventive Services TaskForce. Rockville, MD: Agency for Healthcare Research and Quality, February 2004. Cited: April 10, 2012. Available from URL:
8. Brand RE, Lerch MM, Rubinstein WS etal ; Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007; 56: 1460-9.
9. Ghadirian P, Boyle P, Simard A, Baillargeon J, Maisonneuve P, Perret C. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991; 10: 183-96.
10. Lynch HT, Smyrk T, Kern SE etal. Familial pancreatic cancer: a review. Semin Oncol 1996; 23: 251-75.
11. Fuchs CS, Colditz GA, Stampfer MJ etal. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996; 156: 2255-60.
12. Silverman DT, Dunn JA, Hoover RN etal. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1994; 86: 1510-6.
13. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, DiMagno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001; 286: 169-70.
14. Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003; 124: 1292-9.
15. Klein AP, Brune KA, Petersen GM etal. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004; 64: 2634-8.
16. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995; 273: 1605-9.
17. Mann DV, Edwards R, Ho S, Lau WY, Glazer G. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol 2000; 26: 474-9.
18. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999; 117: 1464-84.
19. Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990; 85: 350-5.
20. Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, Goldenberg DM. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol 2006; 24: 252-8.
21. Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas 1998; 16: 396-401.
22. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999; 131: 247-55.
23. Canto MI, Goggins M, Hruban RH etal. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006; 4: 766-81; quiz 665.
24. Gong PL, Liu TT, Shen XZ. Differentiation of autoimmune pancreatitis with pancreatic carcinoma remains a challenge to physicians. J Dig Dis 2012; 13: 267-73.
25. Larghi A, Verna EC, Lecca PG, Costamagna G. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin Cancer Res 2009; 15: 1907-14.
26. Yasuda I, Iwashita T, Doi S, Nakashima M, Moriwaki H. Role of EUS in the early detection of small pancreatic cancer. Dig Endosc 2011; 23 Suppl 1: 22-5.
27. Huang WC, Sheng J, Chen SY, Lu JP. Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging. J Dig Dis 2011; 12: 401-8.